588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Azd 5153 Acute Myeloid Leukemia	Beat AML, LLC	P1/2	CCC (48)
Baricitinib Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	CCC (48)
Bomedemstat Acute Myeloid Leukemia	Terrence J Bradley, MD	P1/2	CCC (48)
Bsb-1001 Acute Myeloid Leukemia	BlueSphere Bio, Inc	P1/2	CCC (48)
Cart84 Acute Myeloid Leukemia	Gyala Therapeutics	P1/2	CCC (48)
Eltanexor Acute Myeloid Leukemia	Vanderbilt-Ingram Cancer Center	P1/2	CCC (48)
Flumatinib Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P2	CCC (48)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CCC (48)
Letermovir Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (48)
Levetiracetam Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P2	CCC (48)
Ligufalimab Acute Myeloid Leukemia	Akeso	P1/2	CCC (48)
Max-40279-01 Acute Myeloid Leukemia	Maxinovel Pty., Ltd.	P1/2	CCC (48)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (48)
Ocifisertib Acute Myeloid Leukemia	Treadwell Therapeutics, Inc	P1/2	CCC (48)
Olverembatinib Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P1/2	CCC (48)
Rivogenlecleucel Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	CCC (48)
Sonrotoclax Acute Myeloid Leukemia	Ruijin Hospital	P2	CCC (48)
tcb008 Acute Myeloid Leukemia	TC Biopharm	P2	CCC (48)
u32 car-t Acute Myeloid Leukemia	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	P1/2	CCC (48)
ab8939 Acute Myeloid Leukemia	AB Science	P1/2	CC (47)
Anti-Siglec-6 Car-T Cell Therapy Acute Myeloid Leukemia	Xuzhou Medical University	P1/2	CC (47)
ard103 Acute Myeloid Leukemia	ARCE Therapeutics, Inc.	P1/2	CC (47)
Dilanubicel Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2	CC (47)
Fosciclopirox Acute Myeloid Leukemia	CicloMed LLC	P1/2	CC (47)
gb3226 Acute Myeloid Leukemia	Galecto Biotech AB	P1/2	CC (47)
np137 Acute Myeloid Leukemia	Centre Leon Berard	P1/2	CC (47)
Acetylcysteine Acute Myeloid Leukemia	Peking University People's Hospital	P2	CC (46)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CC (46)
Bugitinib Acute Myeloid Leukemia	Shenzhen University General Hospital	P2	CC (46)
BX2 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (46)
bx3 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (46)
BX4 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (46)
Cpx-315 Acute Myeloid Leukemia	Centre Hospitalier Universitaire de Nice	P2	CC (46)
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions Acute Myeloid Leukemia	Michael Pulsipher	P2	CC (46)
dvx201 Acute Myeloid Leukemia	Coeptis Therapeutics	P1	CC (46)
Ebx-102 Acute Myeloid Leukemia	Imperial College London	P2	CC (46)
Erwinia L-Asparaginase Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CC (46)
Fedratinib Acute Myeloid Leukemia	University of Washington	P2	CC (46)
Human Leukocyte Acute Myeloid Leukemia	Brown University	P2	CC (46)
Interferon Gamma-1B Acute Myeloid Leukemia	Sawa Ito, MD	P2	CC (46)
Lilrb4 Star-T Acute Myeloid Leukemia	Hebei Yanda Ludaopei Hospital	P1	CC (46)
Luspatercept Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CC (46)
Lyt-200 Acute Myeloid Leukemia	PureTech	P1	CC (46)
Mgta-456 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CC (46)
Pbsc Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2	CC (46)
Regorafenib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (46)
Retinol Acute Myeloid Leukemia	St. Petersburg State Pavlov Medical University	P2	CC (46)
shr2554 Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P2	CC (46)
Tranexamic Acid Acute Myeloid Leukemia	University of Manitoba	P2	CC (46)
Venclyxto Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	P2	CC (46)

Showing 201 to 250 of 588 assets

PreviousPage 5 of 12Next